CNR1 and obesity due to melanocortin 4 receptor deficiency: Now with significant technological advances and progress in eCBome research, it may be feasible to produce ligands with opposing activation profiles of CB1R and CB2R with high degree of selectivity in obesity, neuropsychiatric and neurodegenerative disorders.